Your browser doesn't support javascript.
loading
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.
Perofsky, Amanda C; Huddleston, John; Hansen, Chelsea; Barnes, John R; Rowe, Thomas; Xu, Xiyan; Kondor, Rebecca; Wentworth, David E; Lewis, Nicola; Whittaker, Lynne; Ermetal, Burcu; Harvey, Ruth; Galiano, Monica; Daniels, Rodney Stuart; McCauley, John W; Fujisaki, Seiichiro; Nakamura, Kazuya; Kishida, Noriko; Watanabe, Shinji; Hasegawa, Hideki; Sullivan, Sheena G; Barr, Ian G; Subbarao, Kanta; Krammer, Florian; Bedford, Trevor; Viboud, Cécile.
Afiliação
  • Perofsky AC; Fogarty International Center, National Institutes of Health, United States.
  • Huddleston J; Brotman Baty Institute for Precision Medicine, University of Washington, United States.
  • Hansen C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, United States.
  • Barnes JR; Fogarty International Center, National Institutes of Health, United States.
  • Rowe T; Brotman Baty Institute for Precision Medicine, University of Washington, United States.
  • Xu X; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.
  • Kondor R; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.
  • Wentworth DE; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.
  • Lewis N; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.
  • Whittaker L; Virology Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), United States.
  • Ermetal B; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.
  • Harvey R; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.
  • Galiano M; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.
  • Daniels RS; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.
  • McCauley JW; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.
  • Fujisaki S; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.
  • Nakamura K; WHO Collaborating Centre for Reference and Research on Influenza, Crick Worldwide Influenza Centre, The Francis Crick Institute, United Kingdom.
  • Kishida N; Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.
  • Watanabe S; Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.
  • Hasegawa H; Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.
  • Sullivan SG; Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.
  • Barr IG; Influenza Virus Research Center, National Institute of Infectious Diseases, Japan.
  • Subbarao K; WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia.
  • Krammer F; WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia.
  • Bedford T; WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australia.
  • Viboud C; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, United States.
medRxiv ; 2023 Oct 03.
Article em En | MEDLINE | ID: mdl-37873362
ABSTRACT
Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997-2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection dynamics, presumably via heterosubtypic cross-immunity.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos